111 related articles for article (PubMed ID: 35946933)
1. Completeness of pharmaceutical industry insulin adverse event reports from Africa and the Middle East.
Mlotshwa CR; Burger JR; Vorster M; Rakumakoe DM; Cockeran M
Expert Opin Drug Saf; 2023 Mar; 22(3):221-229. PubMed ID: 35946933
[TBL] [Abstract][Full Text] [Related]
2. Individual Case Safety Reports Analysis for Patients with Diabetes Mellitus on Insulin in Africa and the Middle East.
Mlotshwa CRN; Burger JR; Vorster M; Rakumakoe DM; Cockeran M
Curr Drug Saf; 2022; 17(3):225-234. PubMed ID: 34749625
[TBL] [Abstract][Full Text] [Related]
3. Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®.
Ampadu HH; Hoekman J; de Bruin ML; Pal SN; Olsson S; Sartori D; Leufkens HG; Dodoo AN
Drug Saf; 2016 Apr; 39(4):335-45. PubMed ID: 26754924
[TBL] [Abstract][Full Text] [Related]
4. An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System.
Marwitz K; Jones SC; Kortepeter CM; Dal Pan GJ; Muñoz MA
Drug Saf; 2020 May; 43(5):457-465. PubMed ID: 31981082
[TBL] [Abstract][Full Text] [Related]
5. Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register.
Wallerstedt SM; Brunlöf G; Sundström A
Drug Saf; 2011 Aug; 34(8):669-82. PubMed ID: 21751827
[TBL] [Abstract][Full Text] [Related]
6. The completeness of adverse drug reaction reports in South Africa: An analysis in VigiBase®.
Matlala MF; Lubbe MS; Steyn H
Afr J Prim Health Care Fam Med; 2023 Jan; 15(1):e1-e9. PubMed ID: 36744452
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal Anti-VEGF Drugs and Signals of Dementia and Parkinson-Like Events: Analysis of the VigiBase Database of Spontaneous Reports.
Sultana J; Scondotto G; Cutroneo PM; Morgante F; Trifirò G
Front Pharmacol; 2020; 11():315. PubMed ID: 32226387
[TBL] [Abstract][Full Text] [Related]
8. Best Practices for Improving the Quality of Individual Case Safety Reports in Pharmacovigilance.
Kumar R; Kumar P; Kalaiselvan V; Kaur I; Singh GN
Ther Innov Regul Sci; 2016 Jul; 50(4):464-471. PubMed ID: 30227026
[TBL] [Abstract][Full Text] [Related]
9. Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance.
Lee I; Jokinen JD; Crawford SY; Calip GS; Kilpatrick RD; Lee TA
Ther Innov Regul Sci; 2021 Jan; 55(1):142-151. PubMed ID: 32720297
[TBL] [Abstract][Full Text] [Related]
10. vigiGrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues.
Bergvall T; Norén GN; Lindquist M
Drug Saf; 2014 Jan; 37(1):65-77. PubMed ID: 24343765
[TBL] [Abstract][Full Text] [Related]
11. Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US.
Bahk CY; Goshgarian M; Donahue K; Freifeld CC; Menone CM; Pierce CE; Rodriguez H; Brownstein JS; Furberg R; Dasgupta N
Pharmaceut Med; 2015; 29(6):331-340. PubMed ID: 26635479
[TBL] [Abstract][Full Text] [Related]
12. Quantity is not enough: completeness of suspected adverse drug reaction reports in Spain-differences between regional pharmacovigilance centres and pharmaceutical industry.
Fernandez-Fernandez C; Lázaro-Bengoa E; Fernández-Antón E; Quiroga-González L; Montero Corominas D
Eur J Clin Pharmacol; 2020 Aug; 76(8):1175-1181. PubMed ID: 32447435
[TBL] [Abstract][Full Text] [Related]
13. Development of a multivariate prediction model to identify individual case safety reports which require clinical review.
Gosselt HR; Bazelmans EA; Lieber T; van Hunsel FPAM; Härmark L
Pharmacoepidemiol Drug Saf; 2022 Dec; 31(12):1300-1307. PubMed ID: 36251280
[TBL] [Abstract][Full Text] [Related]
14. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A
Front Immunol; 2022; 13():956825. PubMed ID: 36177033
[TBL] [Abstract][Full Text] [Related]
15. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017.
Masuka JT; Khoza S
BMC Public Health; 2019 Aug; 19(1):1166. PubMed ID: 31455314
[TBL] [Abstract][Full Text] [Related]
16. Differential completeness of spontaneous adverse event reports among hospitals/clinics, pharmacies, consumers, and pharmaceutical companies in South Korea.
Oh IS; Baek YH; Kim HJ; Lee M; Shin JY
PLoS One; 2019; 14(2):e0212336. PubMed ID: 30763386
[TBL] [Abstract][Full Text] [Related]
17. Leveraging Case Narratives to Enhance Patient Age Ascertainment from Adverse Event Reports.
Pham P; Cheng C; Wu E; Kim I; Zhang R; Ma Y; Kortepeter CM; Muñoz MA
Pharmaceut Med; 2021 Sep; 35(5):307-316. PubMed ID: 34476768
[TBL] [Abstract][Full Text] [Related]
18. The quality assessment of the Japanese Adverse Drug Event Report database using vigiGrade.
Tsuchiya M; Obara T; Miyazaki M; Noda A; Takamura C; Mano N
Int J Clin Pharm; 2020 Apr; 42(2):728-736. PubMed ID: 32020439
[TBL] [Abstract][Full Text] [Related]
19. An analysis of the trends, characteristics, scope, and performance of the Zimbabwean pharmacovigilance reporting scheme.
Masuka JT; Khoza S
Pharmacol Res Perspect; 2020 Oct; 8(5):e00657. PubMed ID: 32930524
[TBL] [Abstract][Full Text] [Related]
20. Patterns of spontaneous reports on narcolepsy following administration of pandemic influenza vaccine; a case series of individual case safety reports in Eudravigilance.
Gadroen K; Straus SMJM; Pacurariu A; Weibel D; Kurz X; Sturkenboom MCJM
Vaccine; 2016 Sep; 34(41):4892-4897. PubMed ID: 27577558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
